title: Mycobacterium bovis BCG and New Vaccines for the Prevention of Tuberculosis.
abstract: Tuberculosis infects millions of people worldwide and remains a leading global killer despite widespread neonatal administration of the tuberculosis vaccine, bacillus Calmette-Guérin (BCG). BCG has clear and sustained efficacy, but after 10 years, its efficacy appears to wane, at least in some populations. Fortunately, there are many new tuberculosis vaccines in development today, some in advanced stages of clinical trial testing. Here we review the epidemiological need for tuberculosis vaccination, including evolving standards for administration to at risk individuals in developing countries. We also examine proven sources of immune protection from tuberculosis, which to date have exclusively involved natural or vaccine exposure to whole cell mycobacteria. After summarizing evidence for the use and efficacy of BCG, we detail the most promising new candidate vaccines against tuberculosis. The global need for a new tuberculosis vaccine is acute and huge, but clinical trials to be completed in the coming few years are likely either to identify a new tuberculosis vaccine or to substantially reframe how we understand immune protection from this historical scourge.
authors.affiliation: Dartmouth's Geisel School of Medicine.|Section of Infectious Diseases and International Health, Dartmouth-Hitchcock Medical Center.|The Dartmouth Institute for Clinical Practice & Health Policy, Lebanon, NH 03756.
authors.forename: Timothy
authors.initials: T
authors.lastname: Lahey
authors.affiliation: Dartmouth's Geisel School of Medicine.|Section of Infectious Diseases and International Health, Dartmouth-Hitchcock Medical Center.
authors.forename: C Fordham
authors.initials: CF
authors.lastname: von Reyn
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D009163:Mycobacterium bovis / Q000276:immunology*; D009169:Mycobacterium tuberculosis / Q000276:immunology; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control*
chemical_list: D001500:BCG Vaccine